0.6689
5.25%
-0.0371
After Hours:
.67
0.0011
+0.16%
Nexalin Technology Inc stock is traded at $0.6689, with a volume of 52,544.
It is down -5.25% in the last 24 hours and down -27.39% over the past month.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
See More
Previous Close:
$0.706
Open:
$0.6993
24h Volume:
52,544
Relative Volume:
0.12
Market Cap:
$7.08M
Revenue:
$128.60K
Net Income/Loss:
$-4.60M
P/E Ratio:
-1.9111
EPS:
-0.35
Net Cash Flow:
$-3.74M
1W Performance:
-5.32%
1M Performance:
-27.39%
6M Performance:
-52.22%
1Y Performance:
+52.06%
Nexalin Technology Inc Stock (NXL) Company Profile
Name
Nexalin Technology Inc
Sector
Industry
Phone
(832) 260-0222
Address
1776 YORKTOWN, HOUSTON
Nexalin Technology Inc Stock (NXL) Latest News
Neta X Launch Date Revealed, Price Of IDR 400 Million? - VOI English
World of light and colour on its way to city centre - Newark Advertiser
NEXT Biometrics Expands in India with New Order - TipRanks
Business News | Content-sharing Startup Newzo Mobile App Gets Seed Funding by Concept PR Mumbai - LatestLY
Tetra Pak and NIFTEM Sign MoU to Advance Food Processing Innovation in India - ThePrint
Content-Sharing Startup Newzo Mobile App Gets Seed Funding By Concept PR Mumbai - Zee News
Nexalin Technology Welcomes New SVP Carolyn Shelton - TipRanks
This smallcap IT stock gave 191% returns in last one year, hits new all-time high; here's why - Upstox
Nexalin Technology Inc (NXL) Stock: A Year of Declines and Increases - The InvestChronicle
Daily Progress: Nexalin Technology Inc (NXL) Drop -10.32, Closing at 0.85 - The Dwinnex
Nexalin Technology Participates in Congressional Roundtable - GlobeNewswire
Nexalin Technology Participates in Congressional Roundtable Focused on Emerging Virtual Therapeutic Options for Opioid Treatment - StockTitan
Nexalin Technology shareholders approve board, plan amendment - Investing.com India
Nexalin Technology shareholders approve board, plan amendment - Investing.com
Nexalin Technology shareholders approve board, plan amendment By Investing.com - Investing.com UK
Nexalin Technology Inc [NXL] Investment Guide: What You Need to Know - Knox Daily
Nexalin Technology Granted U.S. Patent For DBS Device - MPO-mag
Nexalin Technology Second Quarter 2024 Earnings: US$0.17 loss per share (vs US$0.11 loss in 2Q 2023) - Yahoo Finance
Nexalin Technology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Nexalin Technology announces executive departure By Investing.com - Investing.com Australia
Nexalin Technology announces executive departure - Investing.com
Nexalin Technology announces executive departure By Investing.com - Investing.com Canada
Nexalin Technology SVP Michael Nketiah Announces Resignation - TipRanks
Nexalin Technology : Discover Nexalin’s Neurostimulation Device Targeting Mental Health Disorders - Marketscreener.com
Head-To-Head Survey: Nexalin Technology (NASDAQ:NXL) & CONMED (NYSE:CNMD) - Defense World
Nexalin Technology (NASDAQ:NXL) Stock Quotes, Forecast and News Summary - Benzinga
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - StockTitan
Nexalin Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - AccessWire
LOBO EV and Nexalin Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - StockTitan
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery - GlobeNewswire
Nexalin Technology Selected to Join Industry Coalition: Breaking Barriers to Substance Use Recovery - StockTitan
Nexalin Technology Inc’s latest rating changes from various analysts - Knox Daily
Nexalin Technology Regains Nasdaq Compliance - Investing.com India
Nexalin Technology Regains Nasdaq Compliance - Investing.com
NXL Stock Sees Decline of Approximately -3.97% in Last Five Days - Knox Daily
Stocks of Nexalin Technology Inc (NXL) are poised to climb above their peers - SETE News
Financial Metrics Check: Nexalin Technology Inc (NXL)’s Ratios for Trailing Twelve Months - The Dwinnex
Was there any good news for Nexalin Technology Inc (NXL) stock in the last session? - US Post News
Understanding the Risks of Investing in Nexalin Technology Inc (NXL) - Knox Daily
Nexalin Technology Inc’s Mixed Bag: Up 230.68% in 6 Months, Up 81.69% in 30 Days - The InvestChronicle
NXL Stock Price and Chart — NASDAQ:NXL - TradingView
Nexalin Technology Inc [NXL] Shares Jump Approximately 57.80% Over the Year – Knox Daily - Knox Daily
Nexalin Technology (NXL) & Its Competitors Critical Review - Defense World
Nexalin Technology Announces Closing of $5.2 Million Public Offering - Quantisnow
Stocks of Nexalin Technology Inc (NXL) are poised to climb above their peers – Sete News - SETE News
Contrasting Nexalin Technology (NXL) and Its Peers - Defense World
Reviewing Nexalin Technology (NASDAQ:NXL) and Positron (OTCMKTS:POSC) - Defense World
Nexalin Technology Announces Closing of $5.2 Million Public Offering - StockTitan
Nexalin technology's chief medical officer buys $1,750 in company stock By Investing.com - Investing.com Australia
The 3 Smartest Penny Stocks to Buy With Your Money Right Now - InvestorPlace
Nexalin Technology Inc Stock (NXL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):